Screening and Validation of Tumorigenicity-related CircRNAs in MDCK Cells
YANG Di1,2,3,4, SHI Jia-Chen2,3, HUANG Ling-Wei2,3, WANG Jia-Min2,3, MA Yu-Mei5, QIAO Zi-Lin2,3, CUI Yan1,*
1 College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730070, China; 2 Engineering Research Center for Key Technologies and Industrialization of Cell-based Vaccines, Ministry of Education, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, China; 3 Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, China; 4 Department of Experiment & Teaching, Northwest Minzu University, Lanzhou 730030, China; 5 Gansu Provincial Bioengineering Materials Engineering Research Center, Lanzhou Minhai Bio-engineering Co., Ltd., Lanzhou 730010, China
Abstract：In the preparation of animal vaccines such as avian influenza using the canine (Canis lupus familiaris) kidney cell line Madin-Darby canine kidney (MDCK), it was found that the MDCK cell line has tumorigenicity. In this study, highly tumorigenic and non-tumorigenic MDCK cells were selected for RNA-seq high-throughput sequencing. The differentially expressed circular RNA (circRNA) were obtained, and their source genes were analyzed by GO and KEGG. The StarBase and mirTarBase databases were used to predict target microRNA (miRNA) and mRNA of tumorigenic circRNA. Total RNA of tumorigenic and non-tumorigenic MDCK cells were extracted using TRIzol method, and the expression levels of 6 differential circRNAs were verified by qPCR. The results showed that 3 491 circRNAs were identified with the length of 200~800 nt. Among the screened out 27 differentially expressed circRNAs, 18 were up-regulated and 9 were down-regulated. GO, KEGG and Reactome enrichment analysis revealed that differentially expressed circRNAs were associated with ATP activity and amino acid metabolism-related enzymes, linked to adhesion, migration, and various metabolic pathways. The network construction of competing endogenous RNA (ceRNA) illustrated 4 key circRNA-miRNA-mRNA regulatory network related to MDCK cell tumorigenicity, novel_circ_002222/novel-m0145-3p/dynactin 1 (Dctn1), novel_circ_002222/miR-197-x1/Dctn1, novel_circ_001205/novel-m0580-5p/annexin A11 (ANXA11), and novel_circ_003257/novel-m0675-3p/RNA-binding protein 48 (RBM48). The above results indicate that differentially expressed circRNAs related to tumorigenicity in MDCK cells are mainly enriched in transmembrane material transport and energy metabolism-related pathways, which might play a role in energy uptake and metabolism in MDCK cells. This study provides a research foundation and technical support for revealing the mechanism of circRNA involvement in MDCK cell tumorigenesis and establishing genetically engineered non-tumorigenic MDCK cell lines.
杨迪, 石嘉琛, 黄玲巍, 王家敏, 马玉梅, 乔自林, 崔燕. MDCK细胞成瘤性相关环状RNA的筛选与验证[J]. 农业生物技术学报, 2024, 32(9): 2088-2099.
YANG Di, SHI Jia-Chen, HUANG Ling-Wei, WANG Jia-Min, MA Yu-Mei, QIAO Zi-Lin, CUI Yan. Screening and Validation of Tumorigenicity-related CircRNAs in MDCK Cells. 农业生物技术学报, 2024, 32(9): 2088-2099.
[1] 马桂兰. 2021. 低成瘤性MDCK单克隆细胞系的建立、成瘤性分析及应用研究[D]. 博士学位论文, 甘肃农业大学, 导师: 胡永浩, pp. 35-43. (Ma G L.2021. Establishment, tumorigenicity analysis and application of MDCK monoclonal cell line with low tumorigenicity[D]. Thesis for Ph.D., Gansu Agricultural University, Supervisor: Hu Y H, pp. 35-43.) [2] 石嘉琛. 2022. miR-2779-x对MDCK细胞成瘤性的作用研究[D]. 硕士学位论文, 西北民族大学, 导师: 阿依木古丽•阿不都热依木,pp. 14-24. (Shi J C.2022. Effect of miR-2779-x on tumorigenicity of MDCK cells[D]. Thesis for M.S., Northwest Minzu University, Supervisor: Ayimuguli A, pp. 14-24.) [3] Audsley J M, Tannock G A.2005. The growth of attenuated influenza vaccine donor strains in continuous cell lines[J]. Journal of Virological Methods, 123(2): 187-193. [4] Audsley J M, Tannock G A.2008. Cell-based influenza vaccines: Progress to date[J]. Drugs, 68(11): 1483-1491. [5] Capellini F M, Vencia W, Amadori M, et al.2020. Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors[J]. Cytotechnology, 72(1): 97-109. [6] Chen S, Zhou Y, Chen Y, et al.2018. Fastp: An ultra-fast all-in-one FASTQ preprocessor[J]. Bioinformatics, 34(17): i884-i890. [7] Fei C, Gao J, Fei C, et al.2022. A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9)[J]. Journal of Virological Methods, 301: 114408. [8] Gong L J, Wang X Y, Yao X D, et al.2021. CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop[J]. Cell Death & Disease, 12(11): 1081. [9] Hsu S D, Lin F M, Wu W Y, et al.2011. MiRTarBase: A database curates experimentally validated microRNA-target interactions[J]. Nucleic Acids Research, 39: D163-D169. [10] Hua K, Li Y, Zhao Q, et al.2018. Downregulation of annexin a11 (ANXA11) inhibits cell proliferation, invasion, and migration via the AKT/GSK-3β pathway in gastric cancer[J]. Medical Science Monitor, 24: 149-160. [11] Jeck W R, Sharpless N E.2014. Detecting and characterizing circular RNAs[J]. Nature Biotechnology, 32(5): 453-461. [12] Kim D, Langmead B, Salzberg S L.2015. HISAT: A fast spliced aligner with low memory requirements[J]. Nature Methods, 12(4): 357-360. [13] Kluge S, Benndorf D, Genzel Y, et al.2015. Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension[J]. Vaccine, 33(35): 4269-4280. [14] Langmead B, Salzberg S L.2012. Fast gapped-read alignment with Bowtie 2[J]. Nature Methods, 9(4): 357-359. [15] Li J H, Liu S, Zhou H, et al.2014. StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J]. Nucleic Acids Research, 42: D92-D97 [16] Li M, Zhang M, Chen M, et al.2022. KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis[J]. Cell Cycle, 21(13): 1376-1390. [17] Li W, Yang F Q, Sun C M, et al.2020. CircPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma[J]. Theranostics, 10(10): 4395-4409. [18] Liu Z, Wang R, Zhu G.2021. Circ_0035483 functions as a tumor promoter in renal cell carcinoma via the miR-31-5p-mediated HMGA1 upregulation[J]. Cancer Management Research, 13: 693-706. [19] Loiselle J J, Roy J G, Sutherland L C.2017. RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5[J]. PLOS ONE, 12(6): e0180258. [20] Ma G L, Qiao Z L, He D, et al.2020. Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks[J]. Biologicals, 68: 112-121. [21] Memczak S, Jens M, Elefsinoti A, et al.2013. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature, 495(7441): 333-338. [22] Murata H, Omeir R, Tu W, et al.2019. Responsiveness to basement membrane extract as a possible trait for tumorigenicity characterization[J]. Vaccine: X, 1: 100004. [23] Omeir R, Thomas R, Belete T.2015. A novel canine kidney cell line model for the evaluation of neoplastic development: Karyotype evolution associated with spontaneous immortalization and tumorigenicity[J]. Chromosome Research, 23(4): 663-680. [24] Omeir R L, Belete T, Foseh G S, et al.2011. Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells[J]. Comparative Medicine, 61(3): 243-550. [25] Onions D, Egan W, Jarrett R, et al.2010. Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine[J]. Biologicals, 38(5): 544-551. [26] Qiao Z, Yang D, Liu L, et al.2020. Genome-wide identification and characterization of long non-coding RNAs in MDCK cell lines with high and low tumorigenicities[J]. Genomics, 112(2): 1077-1086. [27] Su X, Li H, Chen S, et al.2021. Study on the prognostic values of dynactin genes in low-grade glioma[J]. Technology in Cancer Research & Treatment, 20: 15330338211010143. [28] Subbiah V, Mcmahon C, Patel S, et al.2015. STUMP un"stumped": Anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion[J]. Journal of Hematology & Oncology, 8: 66. [29] Van Wielink R, Kant-eenbergen H C, Harmsen M M, et al.2011. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines[J]. Journal of Virological Methods, 171(1): 53-60. [30] Vo J N, Cieslik M, Zhang Y, et al.2019. The landscape of circular RNA in cancer[J]. Cell, 176(4): 869-881. [31] Wang J, Liu L, Yang D, et al.2022. Identification and differential expression of microRNAs in Madin-Darby canine kidney cells with high and low tumorigenicities[J]. Genes & Genomics, 44(2): 187-196. [32] Wang S, Wang Q, Zhang X, et al.2018. Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma[J]. Cancer Management and Research, 10: 5807-5824. [33] Yang D, Huang L, Wang J, et al.2023. Tumorigenesis mechanism and application strategy of the MDCK cell line: A systematic review[J]. Biologicals, 83: 101699. [34] Zhang J, Goel A, Zhu L.2021. Identification of novel alternative splicing events associated with tumorigenesis, protein modification, and immune microenvironment in early-onset gastric cancer[J]. Frontiers in Oncology, 11: 640272. [35] Zhang P, Wu W, Chen Q, et al.2019. Non-coding RNAs and their integrated networks[J]. Journal of Integrative Bioinformatics, 16(3): 20190027.
